Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Testing effectiveness (Phase 2)Study completedNCT00003549What this trial is testingS9716: Combination Chemotherapy in Treating Patients With Merkel Cell CancerWho this might be right forNeuroendocrine Carcinoma of the Skin SWOG Cancer Research Network 80
Testing effectiveness (Phase 2)Ended earlyNCT04260802What this trial is testingEvaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersWho this might be right forCancerNeoplasmsMetastatic Cancer+16 more Ocellaris Pharma, Inc. 73
Not applicableLooking for participantsNCT06780475What this trial is testingValidation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell CarcinomaWho this might be right forMerkel Cell Carcinoma of Skin Assistance Publique - Hôpitaux de Paris 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03228667What this trial is testingQUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsWho this might be right forNon-Small Cell Lung CancerSmall Cell Lung CancerUrothelial Carcinoma+10 more ImmunityBio, Inc. 40
Early research (Phase 1)Looking for participantsNCT05859074What this trial is testingMQ710 With and Without Pembrolizumab in People With Solid Tumor CancerWho this might be right forCutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more Memorial Sloan Kettering Cancer Center 56
Not applicableLooking for participantsNCT06753136What this trial is testingElectrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any HistotypeWho this might be right forPrimary Visceral Tumors of Any HistotypeVisceral LesionsLiver Cancer+9 more Istituto Oncologico Veneto IRCCS 24
Early research (Phase 1)Looking for participantsNCT05076760What this trial is testingMEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid TumorsWho this might be right forSolid TumorAdvanced CancerMetastatic Cancer+7 more Memgen, Inc. 40
Early research (Phase 1)Active Not RecruitingNCT06014086What this trial is testingIntratumoral PH-762 for Cutaneous CarcinomaWho this might be right forSquamous Cell Carcinoma of the SkinMalignant Melanoma of SkinMerkel Cell Carcinoma of Skin Phio Pharmaceuticals Inc. 30
Testing effectiveness (Phase 2)Looking for participantsNCT05896839What this trial is testingImmunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin CancerWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+10 more National Cancer Institute (NCI) 16
Early research (Phase 1)Ended earlyNCT04234113What this trial is testingStudy of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsWho this might be right forThyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more SOTIO Biotech AG 115
Not applicableLooking for participantsNCT06536257What this trial is testingPersonalised Immunotherapy PlatformWho this might be right forMelanomaCutaneous Squamous Cell CarcinomaBasal Cell Carcinoma+2 more Melanoma Institute Australia 1,000
Early research (Phase 1)Ended earlyNCT04596033What this trial is testingTiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell TherapyWho this might be right forMelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck+6 more Genocea Biosciences, Inc. 49
Not applicableLooking for participantsNCT06608511What this trial is testingLiquid Biomarker Study in Melanoma and Non-Melanoma Skin CancersWho this might be right forSkin CancerMelanoma (Skin Cancer)Basal Cell Carcinoma of Skin+3 more University of Wisconsin, Madison 20
Testing effectiveness (Phase 2)Study completedNCT00004922What this trial is testingIrinotecan in Treating Patients With Advanced Neuroendocrine TumorsWho this might be right forCarcinoma of Unknown PrimaryNeuroendocrine CarcinomaNeuroendocrine Carcinoma of the Skin Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02819843What this trial is testingT-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid TumorsWho this might be right forMelanomaMerkel Cell CarcinomaOther Solid Tumors Memorial Sloan Kettering Cancer Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT07115043What this trial is testingInvestigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsWho this might be right forMelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more AstraZeneca 60
Testing effectiveness (Phase 2)Looking for participantsNCT04349436What this trial is testingStudy to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin MalignanciesWho this might be right forMerkel Cell CarcinomaBasal Cell CarcinomaLocally Advanced Cutaneous Squamous Cell Carcinoma+1 more Replimune, Inc. 90